Christopher Aker

Insider Reports History

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego, CA
Signature
Christopher Aker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Aker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Sr. VP & General Counsel Common Stock 10.1K $12K $1.19 Jan 18, 2024 Direct
Regulus Therapeutics Inc. Sr. VP & General Counsel Stock Option (Right to Buy) 363K May 20, 2024 Direct

Insider Reports Filed by Christopher Aker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. Jan 18, 2024 1 -$6.51K 4 Jan 18, 2024 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. Jan 12, 2024 2 $0 4 Jan 17, 2024 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. Jan 11, 2023 1 $0 4/A Jan 17, 2023 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. May 10, 2022 1 $0 4 May 11, 2022 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. Jan 12, 2022 1 $0 4 Jan 26, 2022 Sr. VP & General Counsel
RGLS Regulus Therapeutics Inc. May 17, 2021 1 -$765 4 May 17, 2021 Sr. VP & General Counsel